Deferred Tax Assets, Valuation Allowance of TELA Bio, Inc. from 31 Dec 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
TELA Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2018 to 31 Dec 2024.
  • TELA Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $76,782,000, a 8% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

TELA Bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $76,782,000 +$5,696,000 +8% 31 Dec 2024 10-K 21 Mar 2025 2024 FY
Q4 2023 $71,086,000 +$10,925,000 +18% 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q4 2022 $60,161,000 +$10,363,000 +21% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q4 2021 $49,798,000 +$8,059,000 +19% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q4 2020 $41,739,000 +$6,928,000 +20% 31 Dec 2020 10-K 23 Mar 2022 2021 FY
Q4 2019 $34,811,000 +$5,424,000 +18% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q4 2018 $29,387,000 31 Dec 2018 10-K 30 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.